共 128 条
[1]
Braak H(1991)Neuropathological stageing of Alzheimer-related changes Acta Neuropathol 82 239-259
[2]
Braak E(1992)Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease Neurology. 42 631-639
[3]
Arriagada PV(2015)Tau imaging early progress and future directions Lancet Neurol 14 114-124
[4]
Growdon JH(2018)The development and validation of tau PET tracers: current status and future directions Clin Transl Imaging 6 305-316
[5]
Hedley-Whyte ET(2017)In vivo tau PET imaging in dementia: pathophysiology, radiotracer quantification, and a systematic review of clinical findings Ageing Res Rev 36 50-63
[6]
Hyman BT(2016)Discovery of 6-(Fluoro-(18)F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([(18)F]-MK-6240): a positron emission tomography (PET) imaging agent for quantification of neurofibrillary tangles (NFTs) J Med Chem 59 4778-4789
[7]
Villemagne VL(2016)Preclinical characterization of 18F-MK-6240, a promising PET tracer for in vivo quantification of human neurofibrillary tangles J Nucl Med 57 1599-1606
[8]
Fodero-Tavoletti MT(2018)In vivo quantification of neurofibrillary tangles with [ Alzheimers Res Ther 10 74-119
[9]
Masters CL(2016)F]MK-6240 Ann Neurol 79 110-269
[10]
Rowe CC(2017)Tau PET imaging in aging and early Alzheimer’s disease J Label Compd Radiopharm 60 263-1179